English | Español
Patient Daily | Feb 22, 2026

Analysis finds most English regions fall short on safe GP staffing levels
Patient Daily | Feb 22, 2026

Researchers outline risks linked to widely used diabetes and weight-loss drugs
Patient Daily | Feb 22, 2026

Positrigo introduces program to expand access to brain PET imaging in U.S. neurology offices
Patient Daily | Feb 22, 2026

Boomerang Ventures invests in IMPOWER HEALTH; appoints Trent McCracken as CEO
Patient Daily | Feb 22, 2026

Ocular Therapeutix’s hydrogel shows stronger results than Eylea in late-stage wet AMD trial
Patient Daily | Feb 22, 2026

Vaxart advances oral norovirus vaccine as rivals face clinical challenges
Patient Daily | Feb 22, 2026

Compass Pathways reports positive phase 3 results for psilocybin-based depression therapy
Patient Daily | Feb 22, 2026

Disc Medicine faces regulatory uncertainty after FDA rejects rare disease drug

Trending
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

BioMarin pauses dosing and enrollment in two Voxzogo studies after safety signal
+ Regulatory
Patient Daily | Mar 20, 2026

Neurosurgeon DiGiorgio on 340B: '340B also takes money from taxpayers and makes everyone’s health insurance more expensive'
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

FDA rejects REGENXBIO’s Hunter syndrome therapy as Denali awaits decision on rival drug
+ Pharmaceuticals
Patient Daily | Mar 19, 2026

BioSpace releases 2026 U.S. Life Sciences Salary Report with compensation insights